Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Strata Skin Sciences, Inc. (SSKN : NSDQ)
 
 • Company Description   
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.

Number of Employees: 106

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.33 Daily Weekly Monthly
20 Day Moving Average: 13,305 shares
Shares Outstanding: 4.17 (millions)
Market Capitalization: $9.72 (millions)
Beta: 0.69
52 Week High: $3.80
52 Week Low: $2.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -4.12% -8.38%
12 Week -7.91% -21.34%
Year To Date -19.93% -25.00%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
5 WALNUT GROVE DRIVE SUITE 140
-
HORSHAM,PA 19044
USA		 ph: 215-619-3200
fax: 215-619-3208		 ir@strataskin.com http://www.strataskinsciences.com
 
 • General Corporate Information   
Officers
Dolev Rafaeli - Chief Executive Officer;President and Director
Uri Geiger - Chairperson
John Gillings - Chief Accounting Officer
Samuel Rubinstein - Director
Christina Allgeier - Director

Peer Information
Strata Skin Sciences, Inc. (HLIS)
Strata Skin Sciences, Inc. (AZTA)
Strata Skin Sciences, Inc. (APYI)
Strata Skin Sciences, Inc. (RNVA)
Strata Skin Sciences, Inc. (HMSY)
Strata Skin Sciences, Inc. (LRSI)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MEDICAL INFO SYS
Sector: Medical
CUSIP: 86272A305
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/13/25
Share - Related Items
Shares Outstanding: 4.17
Most Recent Split Date: 6.00 (0.10:1)
Beta: 0.69
Market Capitalization: $9.72 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.18 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/13/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 3.64
Price/Cash Flow: -
Price / Sales: 0.29
EPS Growth
vs. Year Ago Period: 42.00%
vs. Previous Quarter: 48.67%
Sales Growth
vs. Year Ago Period: 0.86%
vs. Previous Quarter: -28.86%
ROE
06/30/25 - -
03/31/25 - -138.22
12/31/24 - -121.36
ROA
06/30/25 - -
03/31/25 - -24.37
12/31/24 - -25.86
Current Ratio
06/30/25 - -
03/31/25 - 1.05
12/31/24 - 1.13
Quick Ratio
06/30/25 - -
03/31/25 - 0.87
12/31/24 - 0.98
Operating Margin
06/30/25 - -
03/31/25 - -27.22
12/31/24 - -30.05
Net Margin
06/30/25 - -
03/31/25 - -27.22
12/31/24 - -30.05
Pre-Tax Margin
06/30/25 - -
03/31/25 - -27.72
12/31/24 - -30.56
Book Value
06/30/25 - -
03/31/25 - 0.64
12/31/24 - 1.19
Inventory Turnover
06/30/25 - -
03/31/25 - 5.40
12/31/24 - 5.58
Debt-to-Equity
06/30/25 - -
03/31/25 - 5.71
12/31/24 - 3.06
Debt-to-Capital
06/30/25 - -
03/31/25 - 85.09
12/31/24 - 75.34
 

Powered by Zacks Investment Research ©